KS
Kiersten Stead
Venture CapitalActiveManaging Partner DCVC Bio
77
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Kiersten Stead.
Investment Thesis & Strategy
Kiersten Stead, as Managing Partner at DCVC Bio, invests in biotech, consumer internet, enterprise, and food & beverage companies across various stages. They seek to back innovative companies with strong potential for growth and impact within these sectors.
Portfolio Companies
Selected investments from their portfolio of 77 companies
E
Embark Trucks
Other · , 0
e
evonetix
Other · , 0
C
Carbon Health
Other · , 0
E
EARTH AI
Other · , 0
U
Unlearn.AI
Other · , 0
O
Oasis Labs
Other · , 0
G
GitPrime
Other · , 0
E
Element AI
Other · , 0
E
Enzyme
Other · , 0
A
Alation
Other · , 0
B
Beit
Other · , 0
A
Asimov
Other · , 0
Frequently Asked Questions
Kiersten Stead focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Index Ventures
San Francisco, United States · 827 deals
First Round Capital
San Francisco, United States · 742 deals
Benchmark
San Francisco, United States · 600 deals
Founders Fund
San Francisco, United States · 564 deals
Matrix Partners
San Francisco, United States · 549 deals
Bain Capital Ventures
San Francisco, United States · 438 deals